Skip to main content
. 2026 Jul 13;131(9):1452–1460. doi: 10.1007/s11547-026-02259-0

Table 2.

Patient population demographics and clinical characteristics

Frequency (%)
Sex M 136 (69.0%)
Etiology of liver disease Viral 72 (36.5%)
Other etiologies 63 (32.3%)
ALD 40 (20.3%)
MASLD 14 (7,2%)

PSC

Autoimmune

5 (2.5%)

1 (0.5%)

HCC treatment performed before imaging follow-up 105 (53.3%)
RFTA 44 (41.9%)
Surgical resection 23 (21.9%)
TACE 22 (20.9%)
MWA 14 (13.3%)
SIRT 2 (1.9%)
LI-RADS LR <  = 3 134 (68.7%)
LR 4 21 (10.7%)
LR 5 40 (20.5%)
Average (SD)
Age 63.8 (9.0)

ALD: alcohol-associated liver disease; MASLD: metabolic dysfunction-associated liver disease; MWA: microwave ablation; PSC: primary sclerosing cholangitis; RFTA: radiofrequency thermoablation; SIRT: selective internal radiation therapy; TACE: transarterial chemoembolization